Why single-agent EGFR inhibition may fail in 2 dual-driver tumors: Mechanistic implications for

2026 Open access

Read full text
Authors: Tiara S. Jamison
DOI: 10.13140/rg.2.2.33746.41927
Cited by: 0

Fields of Study & Subjects

HER2/EGFR in Cancer Research Lung Cancer Treatments and Mutations Gastrointestinal Tumor Research and Treatment

Publication details

Publication date
1 January 2026
Language
EN